A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
Clinical trial NCT05445232 · COMPLETED
Trial details
- NCT number
- NCT05445232
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2023-02-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.